# DMID 23-0015; Lassa Fever CVD 1000

> **NCT06546709** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Wilbur Chen, MD, MS** · enrollment: 55 (estimated)

## Conditions studied

- Lassa Fever

## Interventions

- **BIOLOGICAL:** LASSARAB+ aPHAD-SEat 700rU
- **BIOLOGICAL:** HDCV Comparator
- **OTHER:** Normal Saline Placebo
- **BIOLOGICAL:** LASSARAB+ aPHAD-SEat 1400rU

## Key facts

- **NCT ID:** NCT06546709
- **Lead sponsor:** Wilbur Chen, MD, MS
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546709, "DMID 23-0015; Lassa Fever CVD 1000". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06546709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*